Literature DB >> 17850777

Plasticity of CD133+ cells: role in pulmonary vascular remodeling.

Marta Díez1, Joan A Barberà, Elisabet Ferrer, Raquel Fernández-Lloris, Sandra Pizarro, Josep Roca, Victor I Peinado.   

Abstract

OBJECTIVE: Studies in pulmonary arteries (PA) of patients with chronic obstructive pulmonary disease (COPD) suggest that bone marrow-derived endothelial progenitor cells (CD133(+)) may infiltrate the intima and differentiate into smooth muscle cells (SMC). This study aimed to evaluate the plasticity of CD133(+) cells to differentiate into SMC and endothelial cells (EC) in both cell culture and human isolated PA.
METHODS: Plasticity of granulocyte-colony stimulator factor (G-CSF)-mobilized peripheral blood CD133(+) cells was assessed in co-cultures with primary lines of human PA endothelial cells (PAEC) or SMC (PASMC) and in isolated human PA. We also evaluated if the phenotype of differentiated progenitor cells was acquired by fusion or differentiation.
RESULTS: The in vitro studies demonstrated CD133(+) cells may acquire the morphology and phenotype of the cells they were co-cultured with. CD133(+) cells co-incubated with human isolated PA were able to migrate into the intima and differentiate into SMC. Progenitor cell differentiation was produced without fusion with mature cells.
CONCLUSIONS: We provide evidence of plasticity of CD133(+) cells to differentiate into both endothelial cells and SMC, reinforcing the idea of their potential role in the remodeling process of PA in COPD. This process was conducted by transdifferentiation and not by cell fusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850777     DOI: 10.1016/j.cardiores.2007.08.007

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Adult bone marrow cells can differentiate into hemopoietic cells and endothelial cells but not into other lineage cells in normal growth and normal life.

Authors:  Seiji Yanai; Yasushi Adachi; Ming Shi; Akio Shigematsu; Chieko Shima; Yuichiro Imai; A-Hon Kwon; Susumu Ikehara
Journal:  Int J Hematol       Date:  2010-01-20       Impact factor: 2.490

Review 2.  Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.

Authors:  Kurt R Stenmark; Maria G Frid; Brian B Graham; Rubin M Tuder
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

3.  CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.

Authors:  L Vroling; J S W Lind; R R de Haas; H M W Verheul; V W M van Hinsbergh; H J Broxterman; E F Smit
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

4.  Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension.

Authors:  Joan Albert Barberà
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

5.  Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease.

Authors:  Sandra Pizarro; Jéssica García-Lucio; Víctor I Peinado; Olga Tura-Ceide; Marta Díez; Isabel Blanco; Marta Sitges; Jordi Petriz; Yolanda Torralba; Pedro Marín; Josep Roca; Joan Albert Barberà
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

6.  A Novel Relative High-Density Lipoprotein Index to Predict the Structural Changes in High-Density Lipoprotein and Its Ability to Inhibit Endothelial-Mesenchymal Transition.

Authors:  Feng-Yen Lin; Yi-Wen Lin; Chun-Ming Shih; Shing-Jong Lin; Yu-Tang Tung; Chi-Yuan Li; Yung-Hsiang Chen; Cheng-Yen Lin; Yi-Ting Tsai; Chun-Yao Huang
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.